A kit adds gesture controls to smart glasses. Teams tailor the experience with text prompts.

Wearable Devices Ltd. (WLDS) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 Wearable Devices Announces First Half 2026 Financial Results and Provides Corporate Update Company reports continued commercial momentum, advances Human Intent Decoding via its Large MUAP Model (LMM), and expands into Physical AI and Next-Gen Hardware Yokne’am Illit,

Wearable Devices (Nasdaq: WLDS, WLDSW) said it has opened early pre-orders for its Mudra Pro for qualified customers and OEMs. The thinner band adds a PPG sensor to its EMG and inertial sensing, targeting enterprise pilots. The company says Mudra Pro supports development via Mudra Studio and its ai6 Labs initiative.

Pharmaceutical companies like Samsung Bioepis, Formycon, Zydus, Celltrion, and Amgen are racing to develop biosimilars for MSD's top-selling cancer drug Keytruda, as its patent nears expiration. Samsung Bioepis filed for FDA approval, while Formycon and Zydus are already under review. MSD is defending its market with a new subcutaneous formulation, Keytruda Qlex, and plans to acquire new drugs.

Intel announced its Nova Lake desktop processor, built on the enhanced 18A-P process, will launch in 2026 and is ahead of schedule. The chip offers up to 9% more speed or 18% lower power compared to 18A. Intel is repurposing Panther Lake wafer capacity for Granite Rapids server chips, indicating a focus on data center and AI demand. Q3 2026 revenue was $16.5B, up 21% YoY, with Client Computing revenue down 5% YoY. Intel expects a PC market slowdown through mid-2027, citing memory price impacts.

Anteris Technologies reported 30-day results from the EMBARK Study for its DurAVR heart valve, showing low pressure gradients, large valve openings, and no valve-related deaths. The study involved 22 patients with severe aortic stenosis. The company is also conducting the PARADIGM trial, a global study comparing DurAVR to existing valves.

HSBC is expanding its AI capabilities in Hong Kong, aiming to double its AI team to 300 specialists and establish a global AI institute by 2027. The bank is investing in AI, blockchain, and post-quantum cryptography to enhance customer services and operational efficiency. HSBC has launched several AI-driven initiatives, including Banker Assist and HSBCnio, and is collaborating with tech firms like Mistral AI, Google, Amazon, and Microsoft.